IRLAB Therapeutics AB (publ) (OM: IRLAB A)
Health Care · Pharmaceuticals · SE
Skr0.85
+36.77% today · -62.6% 1Y
Public summary
A free snapshot of IRLAB Therapeutics AB (publ), with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app IRLAB Therapeutics AB (publ) (OM: IRLAB A) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.52M.
Over the last twelve months the share price has lost 62.6%, trading between 0.62 and 2.44.
Tweenvest scores IRLAB Therapeutics AB (publ) across four factors: quality 35/100, value 79/100. Its strongest factor is value.
IRLAB A price history
Key figures
- Market cap
- $12.52M
- Revenue (TTM)
- $7.19M
- P/E
- -2.17
- EPS
- -0.65
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- Skr2.44
- 52-week low
- Skr0.62
- Avg volume (3M)
- —
- Shares outstanding
- 148.71M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Optimi Health Corp.CNSX: OPTI | $12.86M | CA$3.20 | +1.91% |
| Silco Pharmaceuticals LimitedDSE: SILCOPHL | $12.77M | Tk15.40 | 0.00% |
| Peak Processing LimitedASX: PKP | $12.71M | AU$0.01 | 0.00% |
| PT Phapros TbkIDX: PEHA | $12.60M | Rp268.00 | -2.19% |
| Devonian Health Group Inc.TSXV: GSD | $12.29M | CA$6.30 | -6.67% |
| Klaria Pharma Holding AB (publ.)OM: KLAR | $12.26M | Skr0.50 | +2.03% |
| Rize Oncology Inc.OTCPK: RZON.F | $12.12M | $0.16 | +39,900.00% |
| Lobe Sciences Ltd.CNSX: LOBE | $11.89M | CA$0.05 | 0.00% |